Operating as a technology and services company supporting access to specialty therapies, AssistRx focuses on its stated market and service model. Its platform and teams help life-sciences companies, healthcare providers, and patients navigate enrollment, benefits, affordability, and ongoing support processes. Software, data, pharmacy-service, and operational capabilities connect stakeholders across the treatment-access journey. Roles include engineering, product, pharmacy operations, patient support, analytics, implementation, compliance, and commercial work. The profile is AssistRx and avoids presenting administrative support as clinical care.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
N/A
Founded
2009
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Company Match
Paid Vacation
Paid Holidays
Employee Referral Bonus
AssistRx, an advanced therapy initiation and patient solutions provider, has partnered with Medisafe, a medication engagement platform used by over 13 million patients globally. The collaboration aims to enhance patient engagement through a new user interface powered by Medisafe's intelligent engagement engine. The solution provides personalised interventions and centralised analytics across the full spectrum of patient support programmes, covering benefits verification, prior authorisation, delivery, and long-term adherence. When digital touchpoints are insufficient, built-in escalation pathways connect patients directly to live support specialists. The partnership extends AssistRx's proprietary Advanced eServices suite, which delivers real-time patient data to accelerate onboarding and ensure timely access to support services. Medisafe's Maestro platform enables AssistRx to design and deploy patient journeys with a single orchestration layer, resulting in rapid deployments and configurable journeys.
ORLANDO, Fla., April 02, 2025 (GLOBE NEWSWIRE) -- AssistRx, the advanced therapy initiation and patient solutions provider, today announced it has completed an asset acquisition from AllazoHealth, a healthcare technology company driving therapy initiation, adherence and health outcomes with artificial intelligence (AI)-powered personalization.“This asset acquisition is an example of our continued investment in our organization to strengthen the advanced solutions we offer to our life sciences organization clients,” said Edward Hensley, AssistRx Co-founder and Senior Executive Advisor. “With AllazoHealth assets, AssistRx further differentiates our access, affordability, adherence and engagement solutions with the latest in technology advancements — artificial intelligence — better empowering talent to focus their energies on people, not tasks.”AllazoHealth technology enables one-to-one patient engagement that increases initiation, adherence and health outcomes while optimizing program performance, costs and efficiencies — aligning perfectly with AssistRx’s intentional integration of technology and therapy expertise to enable better results for today’s patients.“Our vision, culture of innovation and commitment to excellence in customer delivery are very aligned with AssistRx. We knew this organization was the best fit to serve our current and future clients,” said AssistRx Chief Product Officer Bill Grambley, former AllazoHealth CEO. “With the integration of our solutions into AssistRx’s portfolio of services, we’re able to impact a wider range of patients, engage them where they are and give them the support they need, when they need it.”The addition of AllazoHealth technology builds upon AssistRx’s robust technology stack. Proprietary Advanced eServices, such as Advanced Benefit Verification, eMedical Benefit Verification, Advanced Prior Authorization, eConsent and eEnrollment, deliver real-time, accurate patient data to accelerate patient onboarding and ensure timely access to support services. As modular solutions, these tools meet patients and healthcare providers (HCPs) where they are, whether that be through a brand’s website (Advanced Gateway), HCP portal (iAssist), the EHR (CoAssist), or other digital and traditional methods via AssistRx Patient Solutions.Learn more about how AssistRx delivers informed access and improved outcomes at www.AssistRx.com.About AssistRxAssistRx has engineered the perfect blend of technology and talent to provide an advanced therapy initiation and patient support solution to improve patient uptake, visibility and outcomes
AssistRx to expand into 54,664 square feet of space in Maitland Florida. AssistRx to expand into 54,664 square feet of space in Maitland Florida.Maitland, Florida — According to state and local development sources, AssistRx plans to build out 54,664 square feet of new space in Maitland. The company plans to occupy the new space at 495 N. Keller Road in Maitland, on or about June 1, 2025. According to the company website AssistRx has engineered the perfect blend of technology and talent to provide life sciences organizations with an advanced therapy initiation and patient support solution that improves patient uptake, visibility and outcomes. Our balanced approach streamlines enrollment, reduces therapy disruptions and provides real-time therapy visibility through an integrated solute on delivering the informed touchpoints that simplify a complex system to enable better results for todays patients
ORLANDO, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- AssistRx, the advanced therapy initiation and patient solutions provider, today launched Advanced Access Anywhere (AAA), a first-of-its-kind solution designed to accelerate therapy initiation and automate patient support program enrollment at the point of the pharmacy claim. AssistRx developed the solution to address a market gap -- patients that are not enrolled into support programs or their only touchpoints with the brand are the point of prescription and dispense.AAA automates eEnrollment and enables patient visibility at the point of pharmacy claim by leveraging the combination of AssistRx’s proprietary technology with its network of more than 61,000 pharmacies nationwide. With AAA, life sciences organizations can eliminate the enrollment form, accelerate speed to therapy and facilitate access from anywhere.Seamlessly integrating within the pharmacy claim submission process, AAA meets healthcare providers (HCPs), pharmacies and patients where they are. AAA achieves rapid access in three easy steps:HCP ePrescribes medication and provides Patient Services card Pharmacy submits claim, triggering eEnrollment and Advanced eServices Patient receives medication and support services“Advanced Access Anywhere expands on our innovative digital intake strategies to integrate seamlessly into existing workflows, establish greater visibility at the pharmacy claim and reduce lengthy access processes to a matter of minutes,” said AssistRx President and CEO Jeff Spafford. “With this new solution, AssistRx enables our life sciences partners to streamline and automate the outdated methods that inhibit patients from getting the medications they need when they need them.”AAA is projected to process $3 billion in pharmacy benefit claims in 2024 through AssistRx’s network of 61,000+ specialty, mail order and retail pharmacies. For each claim, AAA can initiate eEnrollment and other Advanced eServices for consent, coverage, prior authorization services and financial assistance screening and enrollment – such as eConsent, Advanced Benefit Verification, Advanced Prior Authorization and Financial Assistance Access – in under seven seconds.“Whether launching a new program or supporting established therapies dispensed at retail or specialty pharmacies, AAA delivers increased patient uptake, greater visibility and improved outcomes across the product spectrum,” said Spafford
AssistRxThe designation demonstrates a continued commitment to transforming patient livesORLANDO, Fla., April 16, 2024 (GLOBE NEWSWIRE) -- AssistRx, the advanced therapy initiation and patient solutions provider, has again earned the URAC accreditation for Mail Service Pharmacy for its non-commercial specialty pharmacy, ARx Patient Solutions Pharmacy.URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure and risk management. AssistRx pursued and maintained this designation as it designs and implements free drug programs from its 10,000-square-foot non-commercial pharmacy. By achieving this status, AssistRx demonstrates its commitment to increasing patient uptake, facilitating patient visibility and delivering better treatment outcomes.“Life sciences organizations partner with ARx Patient Solutions Pharmacy for free drug dispense and pharmacy services because of our patient-centered focus and robust tech-enabled patient support solutions,” said Jeff Spafford, CEO and president at AssistRx. “This designation, along with our controlled substance license and accreditation from Accreditation Commission for Health Care (ACHC), reinforces why our partners choose us to support their patients.”AssistRx’s free drug pharmacy, combined with its portfolio of Advanced eServices and AssistRx Patient Solutions talented team members, facilitates an innovative patient support approach that can rapidly evolve to meet program needs and an ever-changing specialty pharmaceutical market.“Mail service pharmacies provide a critical connection for patients receiving specialized pharmaceutical care,” said URAC’s President and CEO Shawn Griffin, MD. “URAC’s Mail Service Pharmacy Accreditation recognizes excellence in the areas of pharmacy operations, medication distribution and patient service and communication, all of which are valuable components of the patient care experience. We are proud to recognize AssistRx for achieving URAC’s Mail Service Pharmacy accreditation.”Learn more about how AssistRx delivers informed access and improved outcomes at www.AssistRx.com.About AssistRxAssistRx has engineered the perfect blend of technology and talent to provide an advanced therapy initiation and patient support solution to improve patient uptake, visibility and outcomes